Novel Macrocyclic Peptides Active at Human Melanocortin Receptors: A Preliminary SAR Study

Abstract

The melanocortins are a group of structurally related peptides derived from proopiomelanocortin (POMC), their name from their melanotropic and corticotropic activities and are comprised of adrenocorticotropic hormone (ACTH), α-melanocyte stimulating hormone (α-MSH), β-MSH, and γ-MSH. The effects of melanocortins are mediated by activation of a family of melanocortin receptors (MCRs). Five MCR (MC1R, MC2R, MC3R, MC4R, and MC5R) (Figure 2) genes have been cloned and the receptors pharmacologically characterized [1]. All the melanocortin ligands conserve the core sequence, Trp-Arg-Phe-His. Previous SAR study on melanotropins, in particular on α-MSH, led to the small cyclic peptide MT-II, a potent and non-selective agonist at MCRs.

Related Papers

• → The melanocortin system in leukocyte biology(2006)99 cited
• → Using the human melanocortin-2 receptor as a model for analyzing hormone/receptor interactions between a mammalian MC2 receptor and ACTH(1-24)(2012)35 cited
• → Characterisation of melanocortin receptor subtypes by radioligand binding analysis(1995)131 cited
• → Peripheral Effects of Melanocortins(2000)5 cited
• → Asp10 in Lys-γ2-MSH determines selective activation of the melanocortin MC3 receptor(1998)12 cited